PURE Bioscience (OTCMKTS:PURE – Get Free Report)’s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.06 and traded as high as $0.07. PURE Bioscience shares last traded at $0.07, with a volume of 600 shares changing hands.
PURE Bioscience Stock Performance
The firm has a market capitalization of $9.10 million, a PE ratio of -2.33 and a beta of 0.16. The company has a fifty day moving average price of $0.07 and a two-hundred day moving average price of $0.06.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last posted its earnings results on Monday, March 16th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.44 million during the quarter.
About PURE Bioscience
PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.
PURE’s product suite includes concentrate formulations and ready-to-use solutions.
See Also
- Five stocks we like better than PURE Bioscience
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
